Navigation Links
New idea for targeting the common cancer protein KRAS
Date:10/20/2013

BOSTON Patients with cancers driven by the protein KRAS, which are particularly hard to treat, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

Mutant forms of the protein KRAS are found in approximately 30 percent of all cancers. They are responsible for many of the hallmarks of these cancers, and KRAS is, therefore, considered an important therapeutic target. However, attempts to develop clinically useful KRAS-targeted drugs have been unsuccessful.

"KRAS is a molecular switch," said Michael Burns, a doctor of medicine and doctor of philosophy candidate at Vanderbilt School of Medicine in Nashville, Tenn. "In the 'on' state it transmits signals that drive cell growth and survival. In many cancers, KRAS is permanently in the on state, and it is a highly validated therapeutic target.

"KRAS switches from off to on most efficiently when it is attached to a protein called SOS," explained Burns. "Each SOS protein attaches to two KRAS proteins, and we have identified a number of small molecules that bind to a particular part of SOS when it is in a complex with two KRAS proteins. These small molecules disrupt the function of the complex, ultimately causing inhibition of the signaling pathways downstream of KRAS that drive cell growth and survival. Although our data were generated in biochemical assays and cell lines, they suggest a potential way to therapeutically target KRAS, which has not been possible to date."

KRAS switches from off to on during a process called guanine nucleotide exchange, and SOS increases the rate at which this process occurs. Burns and colleagues hypothesized that small molecules that blocked SOS-mediated guanine nucleotide exchange would prevent KRAS switching on and, therefore, inhibit the signaling
'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. GUARDaHEART Hosts an Unforgettable Evening in Celebration of World Heart Day “Targeting Heart Disease”
2. Targeting memory T-cells in Type 1 diabetes
3. Targeting aggressive prostate cancer
4. Nanodrug targeting breast cancer cells from the inside adds weapon: Immune system attack
5. Cancer research brief: Targeting pancreatic cancer drug resistance
6. Targeting errant immune system enzyme kills myelodysplastic cells
7. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offer Improved hCG Diet Plans Capable of Targeting Stubborn Belly Fat Now Linked With Decreased Bone Density
8. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Offer New Weight Loss Diets that Educate Patients, Targeting Weight Gained During Childhood and Adolescence
9. Overcoming resistance to anti-cancer drugs by targeting cell powerhouses
10. Study Shows Dual Targeting of HER2 and HR-positive Metastatic Breast Cancer Improves Survival Rates
11. Drugs targeting blood vessels may be candidates for treating Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Stress ... stress created from everyday life changes can lead to very serious, life-altering events. ... for coping with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic ...
(Date:9/1/2015)... ... , ... Georgia State University and its partners have introduced ... sexual assaults on their campuses. , The free, evidence-based survey was developed by ... and student affairs professionals responding to calls by the Obama Administration to strengthen ...
(Date:9/1/2015)... London, UK (PRWEB) , ... September 01, 2015 ... ... of a vacuum that creates negative pressure inside a wound to remove exudates, ... market for treatment devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, ...
(Date:9/1/2015)... ... , ... The Jerry Segal Classic to benefit the patients of Magee Rehabilitation ... in Lafayette Hill, PA. Over the past 26 years, the Classic, organized by the ... designed to support patients and their families during their time at Magee Rehabilitation Hospital. ...
(Date:9/1/2015)... Freeport, ME (PRWEB) , ... September 01, 2015 , ... ... a large, new study that followed men and women for 19 years and found ... those who did not take multivitamins. , The report is part of the September ...
Breaking Medicine News(10 mins):Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... JAZZ ) announced today that Robert Myers , the company,s President, will present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24, 2010 ... ... ... ...
... A new exhibition hall dedicated to the discovery ... at the Smithsonian,s National Museum of Natural History. Based on ... Koch (pronounced "coke") Hall of Human Origins will open to ... 3 p.m. Wednesday, March 17, which also marks the ...
... been known that alcohol exposure is toxic to the developing ... problems. Now, a new report out of UCLA shows that ... combination of methamphetamine and alcohol may be even more ... issue of the Journal of Neuroscience , UCLA professor ...
... died soon after than those using Brilinta, study ... a trial comparing two anti-clotting drugs, patients given Brilinta ... than those given Plavix, researchers found. , Both drugs ... the more popular drug, has been linked to potentially ...
... , ... ... PRINCETON, N.J. , March 16 Statement of Betsy Ryan , President and CEO, New Jersey Hospital Association: , ... , ...
... For parents of children with multiple medical problems, keeping up ... medications can be overwhelming, especially for those in challenging socioeconomic ... wind up using the emergency room, the country,s most expensive ... But a growing concept in health care ...
Cached Medicine News:Health News:Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference 2Health News:New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History 2Health News:New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History 3Health News:New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History 4Health News:New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History 5Health News:New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History 6Health News:Researchers ID brain abnormalities in children exposed to methamphetamine in utero 2Health News:Researchers ID brain abnormalities in children exposed to methamphetamine in utero 3Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 2Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 3Health News:NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows 2Health News:Novel 'medical home' program for pediatric patients, families cuts ER visits in half 2Health News:Novel 'medical home' program for pediatric patients, families cuts ER visits in half 3
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Amgen ... collaboration with Novartis in the areas of Alzheimer,s ... entry into Alzheimer,s disease by teaming up with ... disease program directed at genetically predisposed individuals at ... Amgen to focus on the commercialization of its ...
(Date:9/1/2015)... -- AccuTec Blades, Inc. today announced the acquisition of Edgewell ... in May 2015 its intent to discontinue its industrial ... and Obregon, Mexico . Today,s announcement ... Rick Gagliano , the newly-appointed President and ... name, AccuTec Blades, reflects the precision and accuracy of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2
... (NYSE: SYK ) announced today that its Board of Directors has ... July 30, 2010 to shareholders of record at the close of business ... , , ... is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing ...
... ,, MINNEAPOLIS , June 21 HeartSine Technologies Ltd. recently ... of the most exciting companies with operations in the U.S. and Ireland ... Other companies on this year,s ... biggest-selling newspaper serving Irish America , included Aon Corporation, BNY Mellon, Bimeda, ...
Cached Medicine Technology:HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: